BMC cuts through the cloud

I added BMC Software (BMC) to the Barchart Van Meerten New High portfolio.  BMC provides software products on a worldwide basis that significantly increase the productivity, reliability and recoverability of its customers' core information technology operations, including their software applications and the systems on which they run. The company's goal is to help its customers improve the efficiency and productivity of their mainframe and distributed IT systems.

Their Enterprise Service Management Group looks to be a leader in the cloud computer managment technology.  No don't ask me to explain it but I know that's the future.

The stock has a 96% Barchart technical buy signal and hit 15 new highs and gained 10.55% in the last month.  With a price around 48.54 its Relative Strength Index is 71.89% and rising.

Wall Street brokerages think the sales will increase 6.10% next year and earnings per share should increase 7.00%.  I like their 5 year annual EPS growth rate estimated to be 13.07%

The fools on Motley Fool have notice this one too with the CAPS members voting 192 to 21 for the stock to beat the market.  The more experienced All Stars vote 78 to 7.  The Wall Street columnists articles have been positive 14 to 4.

I don't understand cloud technology but I understand the price movement:

• 96% Barchart technical buy signal
• Relative Strength Index of 75.27% and rising
• Wall Street brokerages pushing the stock based on an estimate of a 5 year annual EPS growth rate of 13.07%

Jim Van Meerten is an advisor to Marketocracy Capital Management who uses his model portfolios not only to manage their mutual funds but also their clients Separately Managed Accounts. You can read his blogs about those model portfolios and investing here and on Barchart Portfolio Blogs. Please leave a comment below or email JimVanMeerten@gmail.com.

Disclosure: Jim Van Meerten through Marketocracy Capital Management has an interest in the stocks mentioned in this blog.

Roper measures up

This morning I added Roper Industries (ROP) to the Barchart Van Meerten New High portfolio.  Roper Industries, Inc. designs, manufactures and distributes specialty industrial controls, fluid handling and analytical instrumentation products worldwide, serving selected segments of a broad range of markets such as oil & gas, scientific research, medical diagnostics, semiconductor, microscopy, chemical and petrochemical processing, large diesel engine and turbine/compressor control applications, bulk-liquid trucking, power generation, and agricultural irrigation industries.  Lot's of stuff to monitor!

The stock earned a 96% Barchart technical buy rating as well a hitting 16 new highs and price appreciation of 12.01% in the last 20 trading session.  With a 75.27% rising Relative Strength Index the stock trades around 78.56.

Wall Street brokerages are using 9 buy and 7 hold reports to push this stock to their clients.  A forecast of an 11.60% increase is sales and an 18.80% increase in earnings is nice but the 5 year annual increase of EPS of 15.00% gets my attention for the long term.

Investor sentiment on Motley Fool is high with the CAPS members voting 100 to 7 that the stock will beat the market and the All Stars are in agreement by a vote of 37 to4.  Fool notes that 12 of the last 13 articles about the company have been positive.

I like Roper because:

• 96% Barchart technical buy signal
• Rising Relative Strength if 75.27%
• Wall Street on board with buy report based on double digit increase in sales and earnings
• Positive general investor sentiment

Jim Van Meerten is an advisor to Marketocracy Capital Management who uses his model portfolios not only to manage their mutual funds but also their clients Separately Managed Accounts. You can read his blogs about those model portfolios and investing here and on Barchart Portfolio Blogs. Please leave a comment below or email JimVanMeerten@gmail.com.

Disclosure: Jim Van Meerten through Marketocracy Capital Management has an interest in the stocks mentioned in this blog.

Steris Corp - STE - Added

This morning I added Steris Corp (STE) to the Barchart Van Meerten New High portfolio.  Steris is a leading provider of infection prevention, contamination prevention, and surgical support systems, products, services, and technologies to healthcare, scientific, research, and industrial Customers throughout the world. The Company has over 4,000 Associates (employees) worldwide, including more than 1,200 direct sales, service, and field support personnel. Customer Support facilities are located in major global market centers with manufacturing operations in theUnited States, Canada, Germany, and Finland.

I bought it for price trends but it just might be an Obama Care recipient.

The stock is on a a tear with a 96% Barchart technical buy signal. It was up in 16 of the last 20 session, 5 of the last 5 and up 12.21% in the last month.  It trades around 37.93 and has a Relative Strength Index of 72.59% and rising.

Wall Street analysts approve and have published 5 buy and 2 hold reports.  They predict a 5.50% increase in sales and 11.70% increase in earnings next year with a 10.00% increase in EPS to be expected annually for at least 5 years.

The general investing public as expressed by Motley Fool CAPS members think the stock will beat the market by a vote of 86 to 14 with the more experienced All Stars voting 31 to 1.  Fool notes that of the 10 articles recently written about the company only 1 has been negative.

I bought the stock because:

• 96% Barchart technical buy singal
• 16 new highs and up 12.21% in the last month
• Wall Street predicts double digit increases in EPS for the next 5 years
• Investor sentiment is positive

Jim Van Meerten is an advisor to Marketocracy Capital Management who uses his model portfolios not only to manage their mutual funds but also their clients Separately Managed Accounts. You can read his blogs about those model portfolios and investing here and on Barchart Portfolio Blogs. Please leave a comment below or email JimVanMeerten@gmail.com.

Disclosure: Jim Van Meerten through Marketocracy Capital Management has an interest in the stocks mentioned in this blog.

Star Bulk Carrier - SBLK -- deleted

This morning I deleted Star Bulk Carrier (SBLK) from the Barchart Van Meerten Speculative portfolio for negative price trends:

• 60% Barchart short term technical sell signal
• Trend Spotter (tm) sell signal
• Trading below its 20,50 & 100 day moving averages
• 11.65% off its high
• Relative Strength Index 35.43% and falling

Jim Van Meerten is an advisor to Marketocracy Capital Management who uses his model portfolios not only to manage their mutual funds but also their clients Separately Managed Accounts. You can read his blogs about those model portfolios and investing here and on Barchart Portfolio Blogs. Please leave a comment below or email JimVanMeerten@gmail.com.

Disclosure: Jim Van Meerten through Marketocracy Capital Management has an interest in the stocks mentioned in this blog.

Agnico-Eagle Mines -- AEM -- deleted

This morning I deleted Agnico-Eagle Mines (AEM) from the Barchart Van Meerten New High portfolio for negative price trends:

• 40% Barchart short term technical sell signal
• Trend Spotter (tm) sell signal
• Dropped 9.25% in just a week
• Trading below its 20 and 50 Day moving average
• Relative Strength Index only 36.74% and falling

Jim Van Meerten is an advisor to Marketocracy Capital Management who uses his model portfolios not only to manage their mutual funds but also their clients Separately Managed Accounts. You can read his blogs about those model portfolios and investing here and on Barchart Portfolio Blogs. Please leave a comment below or email JimVanMeerten@gmail.com.

Disclosure: Jim Van Meerten through Marketocracy Capital Management has an interest in the stocks mentioned in this blog.

3 hottest ETFs - 12/16

Hot ETFs are not like hot stocks they move much slower because they are baskets.  On Barchart I use the new high list then sort for frequency.  Lastly use the flipchart feature so you can see for yourself how consistent the current momentum is.  Take a peek at these 3 and put them on your watch lists.

ISE Water Index - (FIW)  --The First Trust ISE Water Index Fund is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before fees and expenses, of an equity index called the ISE Water Index. The ISE Water Index is a modified market capitalization-weighted index comprised of exchange-listed companies that derive a substantial portion of their revenues from the potable and wastewater industry. The Index selects the top 36 stocks in the industry by market capitalization. The Index is rebalanced on the application of the above model on a semi-annual basis.

• 96% Barchart technical buy signal
• 16 new highs in the last month
• Up 9.58% in the last month
• Realative Strength Index 72.22% and rising
• Trading around 22.16 which is above its 50 day moving average of 20.70

PJG - Dynamic Mid-Cap -- The PowerSahres Dynamic Mid Cap Portfolio seeks investment results that correspond generally to the price and yield (before the Fund's fees and expenses) of an equity index called the Dynamic Mid Cap Intellidex Index (the "Underlying Intellidex"). The Underlying Intellidex is comprised of stocks of 150 U.S. mid capitalization companies. Stocks are selected principally on the basis of their capital appreciation potential as identified by NYSE Arca pursuant to a proprietary Intellidex methodology. The Fund will normally invest at least 80% of its total assets in common stocks of mid capitalization companies.

• 96% Barchart technical buy signal
• 14 new highs in the last month
• Up 7.52% in the last month
• Relative Strength Index 67.84% and rising
• Trading around 24.95 which is above its 50 day moving average of 23.69

XLVS - S&P Small-Cap Health Care -- The PowerShares S&P SmallCap Health Care Portfolio ("the Fund") seeks investment results that correspond (before fees and expenses) generally to the price and yield performance of the index called the S&P SmallCap 600 Capped HealthCare Index (the "Underlying Index"). The Underlying Index is comprised of common stocks of U.S. healthcare companies. These are companies that are principally engaged in the business of providing healthcare-related products and services, including biotechnology, pharmaceuticals, medical technology and supplies, and facilities. The Fund will normally invest at least 80% of its total assets in common stocks of small capitalization healthcare companies.

• 100% Barchart technical buy signal
• 15 new highs in the last month
• Up 10.13% in the last month
• Relative Strength Index 75.61% and rising
• Trading around 27.84 which is above its 50 day moving average of 26.03

Remember these are hot only because of recent positive and consistent price momentum.  Do more research before pressing the buy button.

Jim Van Meerten is an advisor to Marketocracy Capital Management who uses his model portfolios not only to manage their mutual funds but also their clients Separately Managed Accounts. You can read his blogs about those model portfolios and investing here and on Barchart Portfolio Blogs. Please leave a comment below or email JimVanMeerten@gmail.com.

Enzo Biochem - ENZ - added

This morning I added a long shot, dark horse candidate Enzo BioChem (ENZO) to the Barchart Van Meerten Speculaive portfolio. The company develops, manufactures and markets health care products based on molecular biology and genetic engineering techniques, and also provides diagnostic services to the medical community. The business activities of the company are performed by one of the company's three wholly-owned subsidiaries--Enzo Diagnostics, Inc., Enzo Therapeutics, Inc., and Enzo Clinical Labs, Inc. The primary focus of the company's research is the development of products based on two technology platforms -- genetic modulation and immune modulation.


I'm calling this a speculative long shot because a lot of analysts including Value Line have beaten this stock up for a long time.  I'm only looking at the recent price momentum and one lone analyst's opinion.


Lately the stock has momentum with 16 new highs and price appreciation of 25.60% in the last 20 trading sessions.  The stock has a 96% Barchart technical buy signal and a Relative Strength Index of 68.30% that is rising.  It recently traded at 5.21 which is well above it's 50 day moving average of 4.47.


The lone analyst made a Strong Buy report based on his thoughts that sales will increase 12.50% this year and 18.20% next year.  As with most pharma companies increases in sales usually effect the bottom line very well.  He estimates an earnings per share increase of 62.70% this year, 109.10% next year and a 5 year annual EPS growth rate of 14.00%.


Some small investors have noticed these projections and the CAPS members on Motley Fool vote 63 to 9 that the stock will out perform the market with the All Stars in agreement 23 to 1.  There have only been 2 articles about the company but both have been positive.


There is a reason the portfolio is called a SPECULATIVE portfolio.  I look for momentum not fundamentals so many of the pick are undiscovered long shots and you need to do your own research before you press the buy button.

• 96% Barchart technical buy signal
• 16 new highs and up 25.60% in the last month
• Only 1 lone analysts liking this stock
• Some positive investor sentiment

Jim Van Meerten is an advisor to Marketocracy Capital Management who uses his model portfolios not only to manage their mutual funds but also their clients Separately Managed Accounts. You can read his blogs about those model portfolios and investing here and on Barchart Portfolio Blogs. Please leave a comment below or email JimVanMeerten@gmail.com.

Disclosure: Jim Van Meerten through Marketocracy Capital Management has an interest in the stocks mentioned in this blog.

Ameron International -- AMN

With the world wide economy poised for expansion there's a lot of money to be made in infrastructure construction projects, so this morning I added Ameron International ( AMN) to the Barchart Van Meerten New High Portfolio.

They are a multinational manufacturer of highly-engineered products and materials for the chemical, industrial, energy, transportation and infrastructure markets. Traded on the New York Stock Exchange, Ameron is a leading producer of water transmission lines; fiberglass-composite pipe for transporting oil, chemicals and corrosive fluids and specialized materials and products used in infrastructure projects. The Company operates businesses in North America, South America, Europe and Asia. It also participates in several joint-venture companies in the U.S. and the Middle East.

Basically AMN will supply the pipes and poles to move petroleum, chemical, water and electricity  They make their products in concrete, steel and fiberglass.

The stock came under my radar when screening on Barchart for stocks hitting new highs.  The stock currently has momentum hitting new highs in 18 of the last 20 trading sessions for a 25.59% gain.  That earned the stock a 96% Barchart technical buy signal.  The Relative Strength Index is 83.69% and rising.  It currently trades around 84.10 which is well above its 50 day moving average of 69.85.

Wall Street brokerage analysts are beginning to notice this company and both of the analysts following them have published Strong Buy reports.  The concensus is for a 9.40% increase in sales and a 32.40% increase in earnings for the coming year.  EPS growth at an annual rate of 12.00%  is expected for the next 5 years.

It seems small investors have beaten the big boys to this stock with the CAPS members on Motley Fool voting 208 to 15 that the stock will beat the market.  The vote of the more experienced All Star group is a solid 81 to 2 for the same result.  Fool notes that the last 4 articles by Wall Street columnists have been positive.


Put this one on your watch list and remember:

• 96% Barchart technical buy signal
• 18 new highs and up 25.59% in the last 20 trading sessions
• Wall Street Strong  Buy recommendations based on increased sales and earnings
• Positive investor sentiment

Jim Van Meerten is an advisor to Marketocracy Capital Management who uses his model portfolios not only to manage their mutual funds but also their clients Separately Managed Accounts. You can read his blogs about those model portfolios and investing here and on Barchart Portfolio Blogs. Please leave a comment below or email JimVanMeerten@gmail.com.

Disclosure: Jim Van Meerten through Marketocracy Capital Management has an interest in the stocks mentioned in this blog.

Reading International -- RDI -- Deleted

This morning I deleted Reading International (RDI) from the Barchart Van Meerten Speculative portfolio for negative price trends:

• 60% Barchart short term technical sell signal
• Trend Spotter (tm) sell signal
• Trading below 20 and 50 day moving averages
• Relative Strength Index 38.27% and dropping

Jim Van Meerten is an advisor to Marketocracy Capital Management who uses his model portfolios not only to manage their mutual funds but also their clients Separately Managed Accounts. You can read his blogs about those model portfolios and investing here and on Barchart Portfolio Blogs. Please leave a comment below or email JimVanMeerten@gmail.com.

Disclosure: Jim Van Meerten through Marketocracy Capital Management has an interest in the stocks mentioned in this blog.

Cypress Sharpridge Investments - CYS - Deleted

This morning I deleted Cypress Sharpridge Investments (CYS) from the Barchart Van Meerten New High portfolio for negative price trends:

• 40% Barchart technical sell signal
• Trend Spotter (tm) sell signal
• Trading below its 20, 50 and 100 daily moving averages
• Relative Strength Index is only 39.09% and tanking

My major rule is always cut losses as soon as possible.

Jim Van Meerten is an advisor to Marketocracy Capital Management who uses his model portfolios not only to manage their mutual funds but also their clients Separately Managed Accounts. You can read his blogs about those model portfolios and investing here and on Barchart Portfolio Blogs. Please leave a comment below or email JimVanMeerten@gmail.com.

Disclosure: Jim Van Meerten through Marketocracy Capital Management has an interest in the stocks mentioned in this blog.

3 stocks for your NASDAQ watch list

Here are 3 NASDAQ stocks that float to the top of my watch list today.  I found them on the Barchart new high lists

Pega Systems (PEGA) -- a leading provider of Customer Relationship Management software that enables transaction-intensive organizations to manage a broad array of customer interactions. Their software enables organizations to deliver high-quality, consistent customer service across today's preferred interaction channels, from the traditional call center environment to Internet self-service. The company's customers represent a wide range of industries, including banking and financial services, insurance, healthcare management, and telecommunications.

• 96% Barchart technical buy signal
• 19 new highs in the last month
• Up 22.41% in the last month
• Relative Strength Index 75.66% and rising
• Trades around 36.50 which is above its 50 day moving average of 29.46

Connecticut Water Systems (CTWS) -- a non-operating holding company whose income comes solely from its subsidiaries. The core business is water service to people throughout towns in Connecticut and Massachusetts.

• 100% Barchart technical buy signal
• 17 new highs in the last month
• Up 10.68% in the last month
• Relative Strength Index 73.79% and rising
• Trades around 27.03 which is above its 50 day moving average of 25.03

Cohu Inc (COHU) -- designs and manufactures electromechanical systems (handlers) that physically put semiconductors in place for testing and interface directly with electronic test equipment (tester) which performs the electrical test of the semiconductor devices. Other products include television cameras, microwave radios and metal detectors for industrial and hobbyist use.

• 96% Barchart technical buy signal
• 16 new highs in the last month
• Up 13.49% in the last month
• Relative Strength Index 69.76% and rising
• Trades around 16.20 which is above its 50 day moving average of 14.36

Jim Van Meerten is an advisor to Marketocracy Capital Management who uses his model portfolios not only to manage their mutual funds but also their clients Separately Managed Accounts. You can read his blogs about those model portfolios and investing here and on Barchart Portfolio Blogs. Please leave a comment below or email JimVanMeerten@gmail.com.

Disclosure: Jim Van Meerten through Marketocracy Capital Management has an interest in the stocks mentioned in this blog.

Perrix Therapeutics Holdings -- PTX -- added

This morning I'm adding a highly speculative stock -- Perrix Therapeutics Holdings ( PTX) to the Barchart Van Meerten Speculative portfolio based mainly on price momentum.

Pernix Therapeutics Holdings Inc.,  is a specialty pharmaceutical company focused on developing and commercializing pharmaceutical products to meet medical needs primarily in pediatrics. The Company's product families include Aldex, Pediatex, Z-Cof, Brovex, ReZyst and QuinZyme. Its ALDEX products are indicated for the treatment of allergies and symptoms of the common cold. PEDIATEX TD is for the treatment of respiratory allergies. Z-COF 8DM is for the treatment of allergies and symptoms of the common cold. The BROVEX products are indicated for the treatment of allergies and symptoms of the common cold. REZYST IM is a chewable tablet probiotic indicated to replace active cultures that are destroyed by diet and antibiotics and to reduce symptoms associated with irritable bowel syndrome and various gastrointestinal issues. QUINZYME is a dissolve tablet for patients with depleted ubiquinone levels and for patients on statin therapy. Pernix is based in Magnolia, Texas.

The stock has shown recent positive price momentum and came up on my Barchart screens of stocks hitting the most frequent new highs and having high technical buy signals.  They have a 100% Barchart technical buy signal after hitting 16 new highs in the last month and price appreciation of 19.47%.  The Relative Strength Index is a solid 68.32% and rising.

The stock is not covered by many Wall Street analysts and those that do follow predict a 86.00% increase in sales and a 68.10% increase in earnings per share for the next year.  They also stick their neck out with a 5 year annual EPS growth rate of 43.00%,

If your looking of an undiscovered company with current price momentum and high double digit growth prospects you might want to put Perrix Therapeutics (PTX) on your watch list.

Jim Van Meerten is an advisor to Marketocracy Capital Management who uses his model portfolios not only to manage their mutual funds but also their clients Separately Managed Accounts. You can read his blogs about those model portfolios and investing here and on Barchart Portfolio Blogs. Please leave a comment below or email JimVanMeerten@gmail.com.

Disclosure: Jim Van Meerten through Marketocracy Capital Management has an interest in the stocks mentioned in this blog.

PFSWeb -- PFSW - Deleted

This morning I'm deleting PFSWeb Inc (PFSW) from the Barchart Van Meerten Speculative portfolio for negative price trends:

• 100% Barchart short term technical sell signal
• Trading below its 20, 50 and 100 day moving averages
• Lost 12.77% in the last week
• Lost 18.76% in the last month
• Relative Strength Index 33.24% and dropping

Jim Van Meerten is an advisor to Marketocracy Capital Management who uses his model portfolios not only to manage their mutual funds but also their clients Separately Managed Accounts. You can read his blogs about those model portfolios and investing here and on Barchart Portfolio Blogs. Please leave a comment below or email JimVanMeerten@gmail.com.

Disclosure: Jim Van Meerten through Marketocracy Capital Management has an interest in the stocks mentioned in this blog.

Evergreen Utilities and High Income Fund - ERH -- deleted

This morning I'm deleting the Evergreen Utilities and High Income Fund (ERH)  from the Barchart Van Meerten New High portfolio for negative price trends:

• 80% Barchart short term technical sell signal
• Lost 3.39% in the last week
• Trading below its 20 and 50 daily moving averages
• Relative Strength Index 35.28% and falling

Jim Van Meerten is an advisor to Marketocracy Capital Management who uses his model portfolios not only to manage their mutual funds but also their clients Separately Managed Accounts. You can read his blogs about those model portfolios and investing here and on Barchart Portfolio Blogs. Please leave a comment below or email JimVanMeerten@gmail.com.

Disclosure: Jim Van Meerten through Marketocracy Capital Management has an interest in the stocks mentioned in this blog.

Right Now Technologies -- RNOW -- deleting

Today I'm deleting Right Now Technologies (RNOW) from the Barchart Van Meerten New High portfolio for negative price trends:

• 100% Barchart short term sell signal
• Lost 10.86% in the last month
• Trading below its 20 and 50 day moving averages
• Relative Strength Index 36.87% and dropping

Jim Van Meerten is an advisor to Marketocracy Capital Management who uses his model portfolios not only to manage their mutual funds but also their clients Separately Managed Accounts. You can read his blogs about those model portfolios and investing here and on Barchart Portfolio Blogs. Please leave a comment below or email JimVanMeerten@gmail.com.

Disclosure: Jim Van Meerten through Marketocracy Capital Management has an interest in the stocks mentioned in this blog.

3 AMEX stocks for your watch list -- 12/14

Here are 3 AMEX stocks I found on Barchart while screening for those stocks hitting the most frequent new highs:

Golf Trust of America (PTX) -- Pernix Therapeutics Holdings Inc., formerly known as Golf Trust of America, Inc., is a specialty pharmaceutical company focused on developing and commercializing pharmaceutical products to meet medical needs primarily in pediatrics. The Company's product families include Aldex, Pediatex, Z-Cof, Brovex, ReZyst and QuinZyme. Its ALDEX products are indicated for the treatment of allergies and symptoms of the common cold. PEDIATEX TD is for the treatment of respiratory allergies. Z-COF 8DM is for the treatment of allergies and symptoms of the common cold. The BROVEX products are indicated for the treatment of allergies and symptoms of the common cold. REZYST IM is a chewable tablet probiotic indicated to replace active cultures that are destroyed by diet and antibiotics and to reduce symptoms associated with irritable bowel syndrome and various gastrointestinal issues. QUINZYME is a dissolve tablet for patients with depleted ubiquinone levels and for patients on statin therapy. Pernix is based in Magnolia, Texas.

• 100% Barchart technical buy signal
• 16 new highs in the last month
• Up 21.33% in the last month
• Relative Strength Index 69.68% and rising

Gormann-Rupp Co (GRC) --The Gorman-Rupp Company designs, manufactures and sells pumps and related equipment (pump and motor controls) for use in water, wastewater, construction, industrial, petroleum, original equipment, agricultural, fire protection, military and other liquid-handling applications. 

• 100% Barchart technical buy signal
• 14 new highs in the last month
• Up 20.66% in the last month
• Relative Strength Index 76.06% and rising

Emergent Group (LZR) -- through its wholly owned subsidiary, PRI Medical Technologies, Inc., provides mobile medical laser and surgical equipment in sixteen states on a per-procedure basis to hospitals, outpatient surgery centers and physicians' offices. Surgical equipment is provided to customers along with technical support personnel to ensure that such equipment is operating correctly. PRI Medical currently offers its services in five states in the western United States and 11 states along the eastern seaboard.

• 88% Barchart technical buy signal
• 12 new highs in the last month
• Up 62.79% in the last month
• Relative Strength Index 90.38% and rising

Jim Van Meerten is an advisor to Marketocracy Capital Management who uses his model portfolios not only to manage their mutual funds but also their clients Separately Managed Accounts. You can read his blogs about those model portfolios and investing here and on Barchart Portfolio Blogs. Please leave a comment below or email JimVanMeerten@gmail.com.

Disclosure: Jim Van Meerten through Marketocracy Capital Management has an interest in the stocks mentioned in this blog.

Mom please send money by Western Union

How many of you when in college or in the service ran into a temporary cash flow problem and placed the call:  "Mom can you please send me a few bucks by Western Union to tide me over?"

The Western Union Company (WU) is a leading provider of global money-transfer services. Together with its affiliates, Orlandi Valuta and Vigo, Western Union provides consumers with fast, reliable and convenient ways to send and receive money around the world, as well as send payments and purchase money orders.

They now have over 410,000 locations in over 200 countries.  I know in my local area some of the customer services desks at the grocery stores are WU locations.  Transaction fees account for 79% of their revenues and consumer to consumer transactions are up over 10%

I noticed this stock on my Barchart screening of S&P 500 companies experiencing recent upward price momentum.  The stocks enjoys a 96% Barchart technical buy signal with the price up 12.67% for the quarter, 3.87% for the month and 2.48% for the last week.  The Relative Strength Index is 52.58% and rising.  The stock trades around $18.72 well above its 50 day moving average of $18.10.

Wall Street brokerage analysts love this stock with 18 buy and 9 hold reports published for their brokers to push to clients.  Although the analysts only look for a 1.60% increase in sales this year and a 4.10% increase next year they have good earnings estimates of an EPS increase of 7.80% this year, 7.90% next year and a 12.46% annual increase for at least the next 5 years.

The general investing public overwhelmingly favors this stock with the CAPS members on Motley Fool voting 1,500 to 44 that the stock will beat the market.  The more experienced All Stars also vote 484 to 6 for the same result.

Of the Wall Street columnists Fool follows all of the last 16 articles have been positive.

If your portfolio needs an S&P 500 core positions consider Western Union (WU) :

• 96% Barchart technical buy signal
• Relative Strength Index 62.58%  and rising
• Wall Street brokerages releasing positive reports based on 5 year EPS growth of double digits
• Wide and positive general investor sentiment
• Financial columnists writing positive articles

Jim Van Meerten is an advisor to Marketocracy Capital Management who uses his model portfolios not only to manage their mutual funds but also their clients Separately Managed Accounts. You can read his blogs about those model portfolios and investing here and on Barchart Portfolio Blogs. Please leave a comment below or email JimVanMeerten@gmail.com.

Disclosure: Jim Van Meerten through Marketocracy Capital Management has an interest in the stocks mentioned in this blog.

3 NYSE stocks -- 12/13

Here are 3 NYSE stocks you might want to add to your watch list.  They were found on the Barchart most new highs list.

Biglari Holdings (BH) -- formerly known as The Steak n Shake Company, is engaged primarily in the ownership, operation, and franchising of restaurants in the United States. Steak n Shake Operations, Inc. (Steak n Shake) is a wholly-owned subsidiary of the Company. Steak n Shake is an American brand serving burgers and milk shakes. It offers its patrons full-service dining with counter and dining room seating, as well as drive-thru and carry-out service. Biglari Holdings is based in San Antonio, Texas.

• 100% Barchart technical buy signal
• 15 new highs in the last month
• Up 21.46% in the last month
• Relative Strength Index 76.74%

Robbins & Myers (RBN) -- is engaged in the design, manufacture, and marketing of fluids management equipment, primarily progressing cavity pumps, chemical reactor and storage vessels, agitators and mixers, and fluoropolymer corrosion-resistant coatings.

• 96% Barchart technical buy signal
• 15 new highs in the last month
• Up 19.22% in the last month
• Relative Strength Index 82.39% and rising

International Coal Group (ICO) -- is a leading producer of coal in Northern and Central Appalachia and the Illinois Basin. The company has eleven active mining complexes, of which ten are located in Northern and Central Appalachia and one in Central Illinois. ICO's mining operations and reserves are strategically located to serve utility, metallurgical and industrial customers throughout the Eastern United States.

• 96% Barchart technical buy signal
• 15 new highs in the last month
• Up 39.22% in the last month
• Relative Strength Index 78.40% and rising

Jim Van Meerten is an advisor to Marketocracy Capital Management who uses his model portfolios not only to manage their mutual funds but also their clients Separately Managed Accounts. You can read his blogs about those model portfolios and investing here and on Barchart Portfolio Blogs. Please leave a comment below or email JimVanMeerten@gmail.com.

Disclosure: Jim Van Meerten through Marketocracy Capital Management has an interest in the stocks mentioned in this blog.

Sappi Ltd -- SPP - deleted

I deleted Sappi Ltd (SPP) from the Barchart Van Meerten Speculative portfolio for negative price trends.

• 40% Barchart short term technical sell signal
• Trading below its 20 and 50 day moving average
• Lost 5.10% in the last week
• Lost 8.73% in the last month
• Relative Strength Index 41.08% and dropping

Jim Van Meerten is an advisor to Marketocracy Capital Management who uses his model portfolios not only to manage their mutual funds but also their clients Separately Managed Accounts. You can read his blogs about those model portfolios and investing here and on Barchart Portfolio Blogs. Please leave a comment below or email JimVanMeerten@gmail.com.

Disclosure: Jim Van Meerten through Marketocracy Capital Management has an interest in the stocks mentioned in this blog.